BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6129759)

  • 1. [New research on the morphology and biology of the Gonococcus].
    Ovchinnikov NM; Dmitriev GA
    Vestn Dermatol Venerol; 1982 Sep; (9):33-40. PubMed ID: 6129759
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antigenic and immunogenic properties of the pili and external wall of the gonococcus].
    Ovchinnikov NM; Delektorskiĭ VV; Timchenko GF; Dmitriev GA
    Vestn Dermatol Venerol; 1981 Jul; (7):11-5. PubMed ID: 6117164
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of the Gonococcus: Disease and Pathogenesis.
    Shaughnessy J; Ram S; Rice PA
    Methods Mol Biol; 2019; 1997():1-27. PubMed ID: 31119614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common pathways of invasion of mucosal barriers by Neisseria gonorrhoeae and Neisseria meningitidis.
    McGee ZA; Stephens DS
    Surv Synth Pathol Res; 1984; 3(1):1-10. PubMed ID: 6150544
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiotype and anti-anti-idiotype antibodies to Neisseria gonorrhoeae lipooligosaccharides with bactericidal activity but no cross-reactivity with red blood cell antigens.
    Brossay L; Paradis G; Pépin A; Mourad W; Coté L; Hébert J
    J Immunol; 1993 Jul; 151(1):234-43. PubMed ID: 7686935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefuroxime treatment of urethritis caused by a beta-lactamase-producing strain of Neisseria gonorrhoeae.
    Normark S; Elmros T; Norlander L; Kjellberg E; Holm S; Burman LA; Bergström S
    Acta Derm Venereol; 1980; 60(3):277-9. PubMed ID: 6158239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of cellular and enzymatic variability of Neisseria gonorrhoeae in the diagnosis and treatment of gonorrhea].
    Trybuła J; Zajac W
    Przegl Dermatol; 1980; 67(3):377-86. PubMed ID: 6776589
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectinomycin as primary treatment of gonorrhea in areas of high prevalence of penicillinase-producing Neisseria gonorrhoeae.
    Berg SW; Harrison WO
    Sex Transm Dis; 1981; 8(1):38-9. PubMed ID: 6452709
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilus peptide vaccine for the prevention of gonorrhea.
    Schoolnik GK; Tai JY; Gotschlich EC
    Prog Allergy; 1983; 33():314-31. PubMed ID: 6187017
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
    Gotschlich EC
    Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic mechanisms of organisms virulent to the eye.
    Watt PJ
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 1)():26-31. PubMed ID: 2872741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili.
    Ofek I; Beachey EH; Bisno AL
    J Infect Dis; 1974 Mar; 129(3):310-6. PubMed ID: 4205880
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells.
    Swanson J
    J Exp Med; 1973 Mar; 137(3):571-89. PubMed ID: 4631989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic composition of the gonococcal strains used in preparing a gonorrhea vaccine].
    Andreeva ZM; Shevchenko NM
    Vestn Dermatol Venerol; 1986; (7):33-5. PubMed ID: 3094267
    [No Abstract]   [Full Text] [Related]  

  • 16. Surface antigens of gonococci: correlation with virulence and serum resistance.
    Demarco de Hormaeche R; Thornley MJ; Holmes A
    J Gen Microbiol; 1983 May; 129(5):1559-67. PubMed ID: 6413645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chick embryo in studies of virulence and immunity with Neisseria Gonorrhoeae.
    Diena BB; Lavergne G; Ryan A; Ashton FE; Wallace R; Perry M; Daoust V
    Rev Can Biol; 1975 Dec; 34(4):213-20. PubMed ID: 819971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial virulence factors--with particular reference to Salmonella bacteria.
    Lindberg AA
    Scand J Infect Dis Suppl; 1980; Suppl 24():86-92. PubMed ID: 6111123
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-lactamase-producing gonococcus as a cause of keratoconjunctivitis].
    Olafsson BM
    Lakartidningen; 1980 Dec; 77(49):4686. PubMed ID: 6783789
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolation of the Gonococcus strains producing beta-lactamase].
    Bednova VN; Zinnurova RS
    Vestn Dermatol Venerol; 1983 Jan; (1):25-7. PubMed ID: 6402860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.